Part: 12         Session: 145678910111213141516171819202122         Page 793794795796797798799800801802803804805806807808809810811812813814815816817818819820821822823824825826827828829830831832833834835836837838839840841842843844845846847848849850851852853854855856857858859860 of 999

Now we did give Dr. Salmon some funds that were given to us in memory of Robert Livingston, a grant of $25,000, and he is trying to test individual human cancers -- grow individual human cancers, tiny samples that have been taken out of people at operations, and he is testing them against leukocyte interferon. He is showing that some tumors respond to it and some don't. You need to have hundreds of tests, and he so far has only done about 57 -- this was a few weeks ago.

So as we get immune interferon, as we get fibroblast interferon, as we get lymphoblastoid, we hope he'll test all of them, and that we'll have some fairly simple tests to show what types of tumors respond to the different kinds of interferon.

We do have now -- he has got quite a large series of patients who were tested against specific drugs that are currently being used, and he is finding that let's say some breast cancers don't respond at all to certain drugs that are being used in a breast cancer regimen, or that in lung cancer certain drugs won't work at all. And as of last spring he was about 95 percent accurate on the things that would work.

But this is something that needs refinement. If you've got it that far along this is something that chemists can refine, and I was hoping he would sell the whole thing to a large drug house who would have commerical chemists who knew how to refine it.